alfuzosin has been researched along with Bladder, Overactive in 4 studies
alfuzosin: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of treatment with alfuzosin 10 mg plus propiverine 10 or 20 mg in men with lower urinary tract symptoms (LUTS) and an overactive bladder were investigated." | 9.19 | Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study. ( Cho, HJ; Cho, JM; Kang, JY; Moon, HS; Seo, DY; Shin, SC; Sung, LH; Yoo, TK; Yu, JH, 2014) |
| "The efficacy and safety of treatment with alfuzosin 10 mg plus propiverine 10 or 20 mg in men with lower urinary tract symptoms (LUTS) and an overactive bladder were investigated." | 5.19 | Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study. ( Cho, HJ; Cho, JM; Kang, JY; Moon, HS; Seo, DY; Shin, SC; Sung, LH; Yoo, TK; Yu, JH, 2014) |
| "Alfuzosin has α1-adrenoreceptor antagonist activity and is available worldwide for the treatment of lower urinary tract symptoms resulting from benign prostate hyperplasia." | 2.48 | Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder. ( Cho, KJ; Kim, JC, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HJ | 1 |
| Shin, SC | 1 |
| Seo, DY | 1 |
| Cho, JM | 1 |
| Kang, JY | 1 |
| Yoo, TK | 1 |
| Yu, JH | 1 |
| Sung, LH | 1 |
| Moon, HS | 1 |
| Cho, KJ | 1 |
| Kim, JC | 1 |
| Sinha, D | 1 |
| Arunkalaivanan, A | 1 |
| Geppetti, P | 1 |
| Nassini, R | 1 |
| Materazzi, S | 1 |
| Benemei, S | 1 |
2 reviews available for alfuzosin and Bladder, Overactive
| Article | Year |
|---|---|
Alfuzosin for the treatment of storage symptoms suggestive of overactive bladder.
Topics: Adrenergic alpha-Antagonists; Animals; Humans; Quinazolines; Urinary Bladder, Overactive | 2012 |
The concept of neurogenic inflammation.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium Channels; Humans; Male; Nerve Tissue Proteins; Neurog | 2008 |
1 trial available for alfuzosin and Bladder, Overactive
| Article | Year |
|---|---|
Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study.
Topics: Benzilates; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pros | 2014 |
1 other study available for alfuzosin and Bladder, Overactive
| Article | Year |
|---|---|
Urethral syndrome: response to alpha-adrenergic blocking agents.
Topics: Adrenergic alpha-Antagonists; Adult; Depression; Female; Humans; Quinazolines; Remission Induction; | 2006 |